Akoya Biosciences Stock Alpha and Beta Analysis

AKYA Stock  USD 2.14  0.06  2.73%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Akoya Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Akoya Biosciences over a specified time horizon. Remember, high Akoya Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Akoya Biosciences' market risk premium analysis include:
Beta
2.3
Alpha
(0.34)
Risk
5.68
Sharpe Ratio
(0)
Expected Return
(0.01)
Please note that although Akoya Biosciences alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Akoya Biosciences did 0.34  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Akoya Biosciences stock's relative risk over its benchmark. Akoya Biosciences has a beta of 2.30  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Akoya Biosciences will likely underperform. At present, Akoya Biosciences' Tangible Book Value Per Share is projected to increase slightly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 4.85, whereas Book Value Per Share is forecasted to decline to 0.91.

Enterprise Value

394.01 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Akoya Biosciences Backtesting, Akoya Biosciences Valuation, Akoya Biosciences Correlation, Akoya Biosciences Hype Analysis, Akoya Biosciences Volatility, Akoya Biosciences History and analyze Akoya Biosciences Performance.
For information on how to trade Akoya Stock refer to our How to Trade Akoya Stock guide.

Akoya Biosciences Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Akoya Biosciences market risk premium is the additional return an investor will receive from holding Akoya Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Akoya Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Akoya Biosciences' performance over market.
α-0.34   β2.30

Akoya Biosciences expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Akoya Biosciences' Buy-and-hold return. Our buy-and-hold chart shows how Akoya Biosciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Akoya Biosciences Market Price Analysis

Market price analysis indicators help investors to evaluate how Akoya Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Akoya Biosciences shares will generate the highest return on investment. By understating and applying Akoya Biosciences stock market price indicators, traders can identify Akoya Biosciences position entry and exit signals to maximize returns.

Akoya Biosciences Return and Market Media

The median price of Akoya Biosciences for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 2.82 with a coefficient of variation of 12.09. The daily time series for the period is distributed with a sample standard deviation of 0.33, arithmetic mean of 2.76, and mean deviation of 0.27. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Acquisition by Frederic Pla of 20000 shares of Akoya Biosciences subject to Rule 16b-3
09/06/2024
2
Akoya Biosciences, Inc.s biggest owners are private equity firms who got richer after stock soared 18 percent last week
09/13/2024
3
Acquisition by Niro Ramachandran of 45000 shares of Akoya Biosciences at 12.3 subject to Rule 16b-3
09/19/2024
4
Acquisition by Mendel Scott of 44959 shares of Akoya Biosciences at 2.68 subject to Rule 16b-3
10/02/2024
5
Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024
10/28/2024
6
Akoya Biosciences Inc Q3 2024 Earnings Report Preview What To Look For
11/13/2024
7
Akoya Biosciences Inc Q3 2024 Earnings Revenue Misses Estimates at 18. ...
11/14/2024
8
Akoya Biosciences, Inc. Q3 2024 Earnings Call Transcript
11/15/2024
9
Akoya Biosciences stock target cut, rating held on recent earnings report
11/19/2024

About Akoya Biosciences Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Akoya or other stocks. Alpha measures the amount that position in Akoya Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2023 2024 (projected)
Dividend Yield0.0022540.002004
Price To Sales Ratio2.242.13

Akoya Biosciences Upcoming Company Events

As portrayed in its financial statements, the presentation of Akoya Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Akoya Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Akoya Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Akoya Biosciences. Please utilize our Beneish M Score to check the likelihood of Akoya Biosciences' management manipulating its earnings.
4th of March 2024
Upcoming Quarterly Report
View
13th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Akoya Biosciences

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Akoya Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akoya Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akoya Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akoya Biosciences Stock:
Akoya Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Akoya Biosciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Akoya Biosciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...